VIVUS LLC is a focused organization dedicated to advancing innovative therapies for patients with serious medical conditions and life-limiting diseases. With over 30 years of experience, VIVUS specializes in developing high-potential molecules with compelling safety and efficacy potential, transforming them into proprietary products that enable significant advances in patient care and outcomes. At VIVUS, our goal is to improve the quality of life for patients, provide healthcare providers with new treatment options, and create value for our shareholders.

We have a strong track record in clinical development and commercialization expertise, allowing us to address the therapeutic needs of patients with unmet medical needs. Led by a seasoned corporate executive team, including John Amos as the Chief Executive Officer, Santosh T. Varghese, MD as the President of VIVUS Global Pharmaceutical Development & Chief Medical Officer, and Kristina Warga as the Senior Vice President & Chief Financial Officer, VIVUS is committed to delivering cutting-edge therapies that make a difference in patients' lives